Exact Sciences Corporation
EXAS
Classificação em ações
#1155
Exact Sciences Corporation specializes in developing and distributing cancer... Exact Sciences Corporation specializes in developing and distributing cancer screening and diagnostic tools across the United States and internationally. Their key product, Cologuard, is an innovative, non-invasive test that analyzes stool-based DNA to identify specific DNA and hemoglobin biomarkers indicative of colorectal cancer and precancerous conditions. The company's extensive portfolio also includes the Oncotype DX family of gene expression tests, designed for breast, prostate, and colon cancers. Within this suite, the Oncotype Test provides detailed tumor profiling from tissue samples, assisting in treatment selection for individuals battling advanced, metastatic, refractory, or recurrent cancers. Furthermore, they offer the Oncotype DX AR-V7 Nucleus Detect Test, a liquid biopsy designed for advanced-stage prostate cancer patients, and Oncomap ExTra, which delivers a comprehensive biological insight into challenging, rare, or aggressive malignancies. Exact Sciences also provides COVID-19 testing services. Future initiatives involve enhancing Cologuard's performance characteristics and pioneering novel blood- and other fluid-based diagnostic tests. The company maintains important license agreements with the MAYO Foundation for Medical Education and Research and Hologic, Inc. Established in 1995, Exact Sciences Corporation's corporate headquarters are located in Madison, Wisconsin.
Preço da ação
$104.91
Última sincronização: 2026-03-23
Valor de mercado
$20.03B
Variação (1 dia)
0.00%
Variação (1 ano)
71.34%
País
US
Negociar Exact Sciences Corporation (EXAS)
Categoria
Healthcare
Margem Operacional de Exact Sciences Corporation (EXAS)
Margem Operacional em October 2026 TTM: -4.11%
De acordo com os relatórios financeiros mais recentes e o preço das ações da Exact Sciences Corporation, a margem operacional atual (TTM) é -4.11%. No final de 2023, a margem operacional era -8.60%.
Histórico da Margem Operacional da Exact Sciences Corporation de 2000 a 2026
Margem Operacional no final de cada ano
| Ano | Margem Operacional | Alterar |
|---|---|---|
| 2026 (TTM) | -4.11% | -89.19% |
| 2024 | -38.01% | 341.98% |
| 2023 | -8.60% | -68.96% |
| 2022 | -27.71% | -41.39% |
| 2021 | -47.28% | 26.28% |
| 2020 | -37.44% | 40.33% |
| 2019 | -26.68% | -23.97% |
| 2018 | -35.09% | -21.11% |
| 2017 | -44.48% | -73.85% |
| 2016 | -170.08% | -57.83% |
| 2015 | -403.35% | -92.79% |
| 2014 | -5,591.71% | 395.54% |
| 2013 | -1,128.40% | -11.17% |
| 2012 | -1,270.32% | 83.48% |
| 2011 | -692.36% | 212.87% |
| 2010 | -221.29% | 14.34% |
| 2009 | -193.53% | -116.82% |
| 2008 | 1,150.29% | -362.79% |
| 2007 | -437.72% | 46.76% |
| 2006 | -298.25% | -18.92% |
| 2005 | -367.86% | -5.42% |
| 2004 | -388.96% | -60.87% |
| 2003 | -994.07% | -71.09% |
| 2002 | -3,438.68% | -93.31% |
| 2001 | -51,406.44% | 0.00% |
| 2000 | 0.00% | 0.00% |
Margem Operacional de empresas semelhantes ou concorrentes
| Empresa | Margem Operacional | Diferença na Margem Operacional | País |
|---|---|---|---|
| 17.97% | -104.37% |
US
|
|
| 20.42% | -104.97% |
US
|
|
| -10.70% | -97.40% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -105.41% |
US
|
O que é a Margem Operacional de uma empresa?
A Margem Operacional é um indicador essencial para avaliar a rentabilidade de uma empresa. Margens operacionais mais altas geralmente são melhores, pois mostram que uma empresa consegue vender seus produtos ou serviços por muito mais do que o custo de produzi-los. É calculada dividindo os lucros da empresa pela sua receita.